Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. | Zendy

Michael D. Cressman | Zendy; Robert Heyka | Zendy; Yen–Hsuan Ni | Zendy; J O'Neil | Zendy; Christine I. Skibinski | Zendy; Hans Hoff | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.

Author(s) -

Michael D. Cressman,

Robert Heyka,

Yen–Hsuan Ni,

J O'Neil,

Christine I. Skibinski,

Hans Hoff

Publication year - 1992

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.86.2.475

Subject(s) - medicine , hemodialysis , lipoprotein(a) , risk factor , population , lipoprotein , coronary artery disease , prospective cohort study , cholesterol , gastroenterology , cardiology , environmental health

Although serum lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerosis in the general population and Lp(a) levels are increased in hemodialysis patients, an association of Lp(a) with the risk of clinical events attributed to atherosclerosis has not been established in the chronic hemodialysis patient population. We therefore determined the association between Lp(a) levels and the risk of clinical events of presumed atherosclerotic etiology in a prospective study of an outpatient hemodialysis population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research